What Intelligence Ventures does

Intelligence Ventures is a pre-seed and seed-stage venture capital firm founded in 2023 and based in Bradenton, United States. The firm deploys checks of $25,000 to $50,000 into early-stage AI healthcare companies headquartered in the US and Canada, organized around four vertical theses: Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS. Its stated investment filter is proprietary data ownership, on the view that AI healthcare winners will be defined by defensible clinical, genomic, imaging, or operational datasets rather than model architecture alone.

The firm's central operating asset is a proprietary research dataset built from reviewing more than 630 AI healthcare startups at the earliest pipeline stage, packaged into an annual 60+ page State of AI Healthcare report covering 19 sections. This research function is the firm's primary differentiator against larger generalist healthcare and AI funds, and it is paired with a 350+ co-investor network and 20-30 inbound founder applications per week. The firm integrates TurboInnovate's AI-powered innovation intelligence platform (from OmniSync Incorporated) into deal screening and provides hands-on commercialization support to select portfolio companies. Its disclosed portfolio includes AGED Diagnostics (AI liver disease diagnostics), HEARTio (AI ECG analysis), Atapir (AI contactless vital sign monitoring), Directed Systems (AI cardiovascular copilot), and Medical Devices Corner (AI-enabled MRI-compatible robotic biopsies), with at least one disclosed co-investment in HEARTio's $4.25 million seed round closed March 2026.

Revenue is generated through standard emerging-manager venture fund economics — management fees on committed capital and carried interest on successful exits — though no fund size, AUM, or LP base is publicly disclosed. The firm is led by Doug Nissinoff (MS), Founder & Managing Partner, alongside Joey Bose (MS), operating with a 1-10 person team.

Name

Intelligence Ventures

Legal name

Intelligence Ventures

Website

https://intelligencevc.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Intelligence Ventures is a US-based pre-seed and seed venture capital firm founded in 2023 that deploys $25K-$50K checks into AI healthcare startups across four verticals in the US and Canada, differentiated by a proprietary research dataset covering 630+ companies.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Miscellaneous Financial Investment Activities (523999)

SIC

Investors, Nec (6799)

akta.pro primary industry

Accelerators & Incubators (Investor-Operated) (FSANAAAM)

akta.pro secondary industry

Technology & Software Growth Equity (FSANACAA)

Keywords

• Venture capital investing
• AI healthcare startups
• Pre-seed seed funding
• Healthcare innovation
• Proprietary data moats

Headquarters

HQ city

Tampa

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Fund Management / Carried Interest: As a venture capital firm, Intelligence Ventures generates returns through equity investments in early-stage AI healthcare companies. Revenue is derived from carried interest on successful exits and management fees.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Intelligence Ventures is a pre-seed and seed-stage venture capital firm that invests $25K–$50K checks in early-stage founders building AI-powered healthcare companies with proprietary data moats across the US and Canada. The firm operates a research-driven investing approach built on proprietary market intelligence covering 630+ startups across four verticals (Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS) and publishes the State of AI Healthcare annual report.

Product overview

Intelligence Ventures is a pre-seed and seed-stage venture capital firm (deploying $25K–$50K checks) focused on AI-powered healthcare companies with proprietary data moats in the US and Canada. The firm operates across four healthcare verticals: Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS. Intelligence Ventures's portfolio includes six AI healthcare companies: AGED Diagnostics (AI-powered liver disease blood tests), HEARTio (AI-driven ECG analysis for cardiac conditions), Atapir (AI-powered contactless vital signs monitoring via computer vision), Directed Systems (AI-powered cardiovascular copilot for surgical/critical care), and Medical Devices Corner (AI-enabled MRI-compatible robotic system for cancer biopsies). The firm differentiates through a research-driven approach and integrates TurboInnovate's AI market intelligence platform into its deal evaluation process.

Differentiator

Problem solved

Functional benefit

Products and services

• Intelligence Ventures Pre-Seed & Seed Fund Pre-seed and seed-stage venture capital fund deploying $25K–$50K check sizes into AI-powered healthcare startups across US and Canada. Targeted at early-stage founders building AI healthcare companies with proprietary data moats across four verticals: Biotech & Pharma Tools, Diagnostics, Medical Devices, and Healthcare SaaS.
• State of AI Healthcare Annual Report A 60+ page annual research publication built from the firm's proprietary dataset covering the earliest-stage AI healthcare pipeline in North America, including 19 sections mapping 4 healthcare verticals. Made available publicly to demonstrate the firm's research-driven thesis and to attract founders and LPs.
• TurboInnovate Market Intelligence Platform Integration An AI-powered innovation intelligence platform integrated into the fund's deal evaluation workflow to assess commercialization potential, competitive positioning, and funding likelihood for pre-seed and seed-stage AI healthcare companies. TurboInnovate's team also provides hands-on commercialization support to select portfolio companies.

Quantifiable outcome

• 630+ startups reviewed and counting

Named customers5 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• TurboInnovatecoreStrategic or Co-development PartnerTurboInnovate, the AI-powered innovation intelligence platform from OmniSync Incorporated, partnered with Intelligence Ventures to integrate its market intelligence platform into the venture capital firm's deal evaluation workflow. Intelligence Ventures uses TurboInnovate to assess commercialization potential, competitive positioning, and funding likelihood for pre-seed and seed-stage AI healthcare companies. TurboInnovate's team also provides hands-on commercialization support to select portfolio companies.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Lux Capital: Early-stage venture firm with deep focus on the intersection of AI/technology and healthcare sciences. Highly comparable to Intelligence Ventures given shared thesis on proprietary data moats and active investing across frontier healthcare categories.
• Section 32: Venture fund founded by Bill Maris focused on healthcare, AI, and frontier technology. Directly comparable to Intelligence Ventures as an early-stage AI/healthcare thesis-driven investor with research-led sourcing.
• Define Ventures: Early-stage venture firm exclusively focused on digital health and healthcare SaaS. Comparable to Intelligence Ventures' Healthcare SaaS vertical and overall pre-seed/seed healthcare investing focus.
• Flare Capital Partners: Early-stage venture firm exclusively focused on digital health and healthcare technology. Directly comparable as a thesis-driven seed/Series A healthcare investor; similar size and stage focus to Intelligence Ventures.
• ARCH Venture Partners: Venture firm focused on early-stage life sciences, diagnostics, and healthcare technology. Directly comparable to Intelligence Ventures' Diagnostics and Biotech & Pharma Tools verticals with deep technical founder relationships.

Broad incumbents

• Optum Ventures: Corporate venture arm of UnitedHealth/Optum investing in AI and digital health. Comparable in AI healthcare thesis but offers strategic payer-provider distribution unavailable to independent VCs like Intelligence Ventures.
• General Catalyst: Multi-stage venture firm with a dedicated Health Assurance and healthcare AI practice. Comparable as an active AI healthcare investor from seed through growth, though vastly larger and broader in mandate.
• Andreessen Horowitz (a16z Bio + Health): Major venture firm with dedicated bio/health fund investing across digital health, therapeutics, and AI healthcare. Comparable in target category but materially larger in AUM, stage range, and competitive deal access.
• Khosla Ventures: Large venture firm with significant dedicated AI and healthcare investing practice. Comparable as a thesis-driven investor in AI healthcare at seed and early stages, though much larger AUM and broader stage mandate.

Emerging players

• Civilization Ventures: Emerging venture firm investing in digital health, computational biology, and AI-driven life sciences. Comparable to Intelligence Ventures as a similarly-sized, thesis-led AI healthcare emerging manager at seed stage.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/intelligencevc
• LinkedInlinkedin.com/company/intelligencevc

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intelligence Ventures